Published in Anticancer Res on January 07, 1999
Calcium-binding proteins in the nervous system. Trends Neurosci (1992) 3.55
Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. Science (1986) 2.07
TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients. Clin Cancer Res (2000) 2.03
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 1.97
AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc Natl Acad Sci U S A (1995) 1.80
Nervous discharges from the olfactory organs of fish. J Physiol (1938) 1.73
Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc Natl Acad Sci U S A (2000) 1.72
Prolonged contraction-relaxation cycle of fast-twitch muscles in parvalbumin knockout mice. Am J Physiol (1999) 1.60
Is high prevalence of Echinococcus multilocularis in wild and domestic animals associated with disease incidence in humans? Emerg Infect Dis (2001) 1.53
Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol (1996) 1.52
Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res (1993) 1.48
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant (2002) 1.46
Calcium-binding protein parvalbumin as a neuronal marker. Nature (1981) 1.45
Calcium-binding protein parvalbumin is associated with fast contracting muscle fibres. Nature (1982) 1.44
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Leukemia (2005) 1.44
Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids. Clin Rheumatol (2001) 1.42
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ (2003) 1.41
Chlamydophila psittaci infections in humans during an outbreak of psittacosis from poultry in Germany. Zoonoses Public Health (2008) 1.31
Alterations in Purkinje cell spines of calbindin D-28 k and parvalbumin knock-out mice. Eur J Neurosci (2000) 1.30
Effects of feedback on daily completion of behavior modification projects. Ment Retard (1973) 1.26
Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. Breast Cancer Res Treat (2001) 1.25
Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol Cell Neurosci (2004) 1.25
Observation of living cells using the atomic force microscope. Biophys J (1993) 1.22
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant (2012) 1.18
Z-DNA immunoreactivity in rat tissues. Nature (1983) 1.14
Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. J Cell Biochem (1991) 1.09
Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium (1993) 1.09
Ontogeny of the calcium binding protein calbindin D-28k in the rat nervous system. Anat Embryol (Berl) (1987) 1.07
Angiotensin II immunoreactivity coexists with renin in the juxtaglomerular granular cells of the kidney. Proc Natl Acad Sci U S A (1981) 1.04
Nucleus basalis Meynert neurons contain the vitamin D-induced calcium-binding protein (Calbindin-D 28k). Anat Embryol (Berl) (1985) 1.04
Distribution of parvalbumin immunoreactivity in the visual cortex of Old World monkeys and humans. J Comp Neurol (1990) 1.02
Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol (1991) 1.01
Ontogeny of the calcium binding protein parvalbumin in the rat nervous system. Anat Embryol (Berl) (1991) 1.01
Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience (2000) 1.00
Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells. Brain Res (2001) 0.99
Monoclonal antibodies directed to human insulin-like growth factor I (IGF I). Use for radioimmunoassay and immunopurification of IGF. FEBS Lett (1982) 0.98
A four-year prospective study on microbial ecology of explanted prosthetic hips in 52 patients with "aseptic" prosthetic joint loosening. Eur J Clin Microbiol Infect Dis (1996) 0.98
Tetanus relaxation of fast skeletal muscles of the mouse made parvalbumin deficient by gene inactivation. J Physiol (2000) 0.98
Immunolocalization of the plasma membrane Ca2+ pump isoforms in the rat brain. Brain Res (1997) 0.98
[Examinations on the behaviour of grampositive and gramnegative bacteria on aluminium foil (author's transl)]. Zentralbl Bakteriol B (1979) 0.97
Changes in cochlear oxygenation, microcirculation and auditory function during prolonged general hypoxia. Eur Arch Otorhinolaryngol (1993) 0.97
N-cadherin/catenin-mediated morphoregulation of somite formation. Dev Biol (1998) 0.96
Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice. Leukemia (2005) 0.95
The selective innervation by serotoninergic axons of calbindin-containing interneurons in the neocortex and hippocampus of the marmoset. J Comp Neurol (1992) 0.95
Parvalbumin in non-muscle tissues of the rat. Quantitation and immunohistochemical localization. J Biol Chem (1984) 0.95
[Physiological parameters of guinea pigs under long-term anesthesia with controlled respiration]. Z Versuchstierkd (1989) 0.94
Intracellular concentration of parvalbumin in nerve cells. Brain Res (1993) 0.94
Protective effect of parvalbumin on excitotoxic motor neuron death. Exp Neurol (2002) 0.93
Intensity-related changes in cochlear blood flow in the guinea pig during and following acoustic exposure. Eur Arch Otorhinolaryngol (1993) 0.93
Development of the calcium-binding protein parvalbumin and calbindin in monkey striate cortex. J Comp Neurol (1991) 0.92
Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam. Neurology (1991) 0.92
Intensity-dependent changes in oxygenation of cochlear perilymph during acoustic exposure. Hear Res (1992) 0.92
Chronic gastritis in tigers associated with Helicobacter acinonyx. J Comp Pathol (1998) 0.92
Laser Doppler measurements of cochlear blood flow during loud sound presentation. Eur Arch Otorhinolaryngol (1990) 0.91
Calbindin immunoreactivity alternates with cytochrome c-oxidase-rich zones in some layers of the primate visual cortex. Nature (1986) 0.91
Calretinin-immunoreactivity during postnatal development of the rat isocortex: a qualitative and quantitative study. Cereb Cortex (1997) 0.90
A comparative study of the backbone dynamics of two closely related lipid binding proteins: bovine heart fatty acid binding protein and porcine ileal lipid binding protein. Mol Cell Biochem (1999) 0.90
Localization of calretinin in cells of layer I (Cajal-Retzius cells) of the developing cortex of the rat. Brain Res Dev Brain Res (1994) 0.90
Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease. Neurobiol Dis (1999) 0.90
Deficiency in parvalbumin, but not in calbindin D-28k upregulates mitochondrial volume and decreases smooth endoplasmic reticulum surface selectively in a peripheral, subplasmalemmal region in the soma of Purkinje cells. Neuroscience (2006) 0.90
Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res (2002) 0.89
Vitamin-D-dependent calcium-binding-protein and parvalbumin occur in bones and teeth. Calcif Tissue Int (1984) 0.88
Charge displacement in bacteriorhodopsin during the forward and reverse bR-K phototransition. Biophys J (1995) 0.88
Measurements of perilymphatic oxygen tension in guinea pigs exposed to loud sound. Eur Arch Otorhinolaryngol (1991) 0.88
Disseminated histoplasmosis and AIDS in Switzerland. Lancet (1986) 0.87
Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci U S A (1989) 0.87
Renin in rat and mouse brain: immunohistochemical identification and localization. Clin Sci (Lond) (1980) 0.87
Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes. Cancer Res (1982) 0.87
Morphological and functional correlates of borders in the entorhinal cortex and hippocampus. Hippocampus (1993) 0.87
Immunohistochemical evidence that angiotensins I and II are formed by intracellular mechanism in juxtaglomerular cells. Hypertension (1982) 0.87
Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide. Biotherapy (1993) 0.87
The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract (1996) 0.86
(133)Xe SPECT cerebral blood flow study in a healthy population: determination of T-scores. J Nucl Med (2001) 0.86
Localization of angiotensinogen in multiple cell types of rat brain. Brain Res (1987) 0.86
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leuk Lymphoma (2009) 0.86
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria. Am J Hypertens (1999) 0.86
Temporal and spatial appearance of the membrane cytoskeleton and perineuronal nets in the rat neocortex. Neurosci Lett (1996) 0.85
Expression of the calcium binding protein calretinin in WiDr cells and its correlation to their cell cycle. Exp Cell Res (1992) 0.85
Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes Relat Metab Disord (2000) 0.85
A polyclonal goat antiserum against the calcium-binding protein calretinin is a versatile tool for various immunochemical techniques. J Neurosci Methods (1999) 0.85
Negative neurofunctional effects of frequency, depth and environment in recreational scuba diving: the Geneva "memory dive" study. Br J Sports Med (2004) 0.85
Production and analysis of transgenic mice with ectopic expression of parvalbumin. Arch Biochem Biophys (1995) 0.85
The hyperreactive malarial splenomegaly syndrome in a European: has the treatment a modulatory effect on the immune system? J Infect Dis (1990) 0.85
[Kala-azar; clinical and physiopathological study a propos of a new case studied in Switzerland]. Schweiz Med Wochenschr (1979) 0.85
[The Schmidt-Lantermann incisures of the myelin sheath of Mauthner axons: site of longitudinal myelin growth]. Brain Res (1976) 0.85
Renin in the human kidney. Immunohistochemical localization. Histochemistry (1981) 0.85
A new myofibrillar protein characteristic of type I human skeletal muscle fibres. Eur J Biochem (1983) 0.85
Interaction of heterozygous beta (0)-thalassemia and triplicated alpha globin loci in a Swiss-Spanish family. Klin Wochenschr (1991) 0.84
Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci Lett (1993) 0.84
Parvalbumin in human brain. J Neurochem (1985) 0.84
Heterogeneity of expression of the calcium-binding protein calretinin in human colonic cancer cell lines. Anticancer Res (1997) 0.84
Distribution of parvalbumin immunoreactivity in the vertebrate retina. Brain Res (1993) 0.83
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation. Bone Marrow Transplant (2007) 0.83
Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript. Leukemia (2005) 0.83
Discrete reduction patterns of parvalbumin and calbindin D-28k immunoreactivity in the dorsal lateral geniculate nucleus and the striate cortex of adult macaque monkeys after monocular enucleation. Vis Neurosci (1994) 0.83
Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status. Br J Cancer (2001) 0.83